Glass tried the injections for his advanced disease, but they did not halt his vision loss. So his ophthalmologist tried ...
Sterling Glass had many health problems as a child—swollen feet, night sweats, nausea and vomiting, unquenchable thirst, and ...
DURAVYU now in Phase 3 for the two largest, multi-billion-dollar retinal disease markets, wet AMD and DME with first patient dosing in pivotal Phase 3 DME trials anticipated in Q1 2026 – – New ...
FDA agrees with Phase 2b/3 clinical design, including primary endpoint and development approach, providing clear regulatory ...
Novo Nordisk saw a competitor’s bet and raised the stakes in metabolic dysfunction-associated steatohepatitis (MASH) with its planned up-to-$5.2 billion acquisition of Akero Therapeutics.
For years a race-based medical calculation delayed Black patients access to life-saving kidney transplants By Anissa Durham ...
Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a clarification to help Nigerians understand its ...
What "Withdrawn," "Suspended," and "Cancelled" Drugs Mean for Nigerians. The National Agency for Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback